Save The Date
Benaroya Research Institute’s second annual Immunology Symposium: New Horizons in Immunity and Disease will be taking place on Monday, April 28, 2025 from 8:30 a.m. – 4:00 p.m. at Town Hall Seattle, followed by a reception at BRI. We’re excited to bring together leading voices from the local and national immunology research community for a day of collaboration, learning, discussion and networking.
2024 was the inaugural year of the event and was a resounding success with a full house, exciting presentations, and impactful conversations. Mark your calendars and reserve the date, additional information, including speakers and program overview, will be coming soon.
2024 BRI Immunology Symposium Speakers
The speakers at the 2024 event included BRI's own Jane Buckner, MD and Jessica Hamerman, PhD as well as invited speakers Neil King, PhD, of the University of Washington; Judith James, MD, PhD, of the Oklahoma Medical Research Foundation; Aaron Ring, MD, PhD, of Fred Hutchinson Cancer Center; and Shaun Jackson, MD, PhD, of Seattle Children’s Research Institute. We will update our list of speakers for the second annual event very soon. Please contact communications@benaroyaresearch.org if you have any questions.
Jane Buckner, MD
Benaroya Research Institute
Jessica Hamerman, PhD
Benaroya Research Institute
Oliver Harrison, DPhil
Benaroya Research Instittue
Shaun Jackson, MD, PhD
Seattle Children’s Research Institute
Judith James, MD, PhD
Oklahoma Medical Research Foundation
Naresh Doni Jayavelu, PhD
Benaroya Research Institute
Neil King, PhD
University of Washington Institute for Protein Design
John Ray, PhD
Benaroya Research Institute
Aaron Ring, MD, PhD
Fred Hutch Cancer Center
Megan Smithmyer, PhD
Benaroya Research Institute
Caroline Stefani, PhD
Benaroya Research Institute
News
Type 1 Diabetes Community Celebrates Research Milestone During National Diabetes Month
Read More
Benaroya Research Institute Names Two New Advisory Board Members
Read More
Benaroya Research Institute Awarded More Than $14 Million Across 11 Grants To Help Predict, Prevent, Reverse and Cure Immune System Diseases
Read More
Featured Publications
Epigenetic trajectory predicts development of clinical rheumatoid arthritis in ACPA+ individuals: Targeting Immune Responses for Prevention of Rheumatoid Arthritis (TIP-RA).
bioRxiv
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy.
Cell Rep
Antigen-specific T cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.
Clin Exp Immunol
Synovial regulatory T cells expressing ST2 deteriorate joint inflammation through the suppression of immunoregulatory eosinophils.
J Autoimmun
B cell adapter for PI 3-kinase (BCAP) coordinates antigen internalization and trafficking through the B cell receptor.
Sci Adv
